BME Insider Trading Activity and SEC Form 4 Filings
BME insider trading summary
No open-market insider purchases or sales of BlackRock Health Sciences Trust (BME) have been reported on SEC Form 4 in the past 12 months.
Latest BME insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 28, 2019 | Cynthia Egan | Director | Buy | $145K (3,737 @ $38.92) |
| Dec 9, 2014 | Henry Gabbay | Director | Sell | $27K (650 @ $42.19) |
| Sep 19, 2012 | Michael J Castellano | Director | Buy | $11K (400 @ $27.71) |
| Apr 28, 2011 | Dick Davis | Director | Buy | $25K (875 @ $28.55) |
| Feb 5, 2010 | Henry Gabbay | Director | Buy | $3K (100 @ $25.57) |
| Feb 21, 2008 | Karen P Robards | Director | Buy | $13K (500 @ $25.42) |
| Feb 15, 2008 | Jerrold B Harris | Director | Buy | $3K (100 @ $25.61) |
| Feb 6, 2008 | Kent Dixon | Director | Buy | $14K (500 @ $27.43) |
| Feb 6, 2008 | Kent Dixon | Director | Buy | $14K (500 @ $27.42) |
| Feb 5, 2008 | W Carl Kester | Director | Buy | $3K (100 @ $26.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.